![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_123,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/SonomaEye-full-color-vector%5B2%5D.png)
Free Paper 2
Sunday, 3/27/22
10:00 AM - 11:30 AM
Moderators: Erik Letko, Jimmy Lee, Hassan Khojasteh
10:00 am – 10:10 am: Novel Use of Acthar Gel for Treatment of Inflammation Driven Limbal Stem Cell Deficiency. John C. Affeldt, MD
10:10 am – 10:20 am: Long-term Efficacy and Safety of Satralizumab in Adults with AQP4-IgG+ Neuromyelitis Optica Spectrum disorder: Results from the Phase 3 SAkura Studies. Shervin Gholizadeh Moghaddam, PharmD, PhD
10:20 am – 10:30 am: Novel Retinopathy in Pediatric Retinal Vasculitis: Long Term Follow Up. Cigdem Yasar, MD
10:30 am – 10:40 am: Suprachoroidal Use of Triamcinolone Acetonide: A Post-Hoc Analysis of PEACHTREE to Evaluate Elevations in Intraocular Pressure. Christopher Or, MD
10:40 am – 10:50 am: Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Macular Edema Associated with Uveitis: Visual and Anatomic Outcomes by Age. Christopher R. Henry, MD (Recorded)
10:50 am – 11:00 am: Newly Diagnosed Central Serous Chorioretinopathy: Demographics and Epidemiology from the IRIS Registry. Kapil Mishra, MD (Recorded)
11:00 am – 11:50 am: DISCUSSION